ected_VBN ,_, and_CC will_MD necessitate_VB restaging_VBG the_DT cancer_NN ,_, as_RB well_RB as_IN a_DT discussion_NN of_IN possible_JJ salvage_NN therapies_NNS with_IN the_DT patient_NN including_VBG radiation_NN or_CC hormonal_JJ therapy_NN ,_, experimental_JJ protocols_NNS or_CC observation_NN =_JJ -_: =[_NN 8_CD -RRB-_-RRB- -_: =_SYM -_: ._.
Thus_RB ,_, the_DT ability_NN to_TO predict_VB which_WDT patients_NNS will_MD have_VB a_DT BCR_NN would_MD be_VB very_RB important_JJ to_TO urologists_NNS and_CC oncologists_NNS in_IN managing_VBG the_DT course_NN of_IN future_JJ treatment_NN ._.
A_DT number_NN of_IN prostate_NN cancer_NN nomograms_NNS wh_VBP
